Companies › TNON

Tenon Medical Inc (TNON)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001560293 · EDGAR filings · Updated 2026-07-24

Tenon Medical Inc (TNON) has reported institutional ownership of 3.3%, with 12 institutional managers holding positions valued at $266.7K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-07-13 — DEFR14A filed
• 2026-07-10 — Current report (8-K) filed
• 2026-07-06 — SCHEDULE 13G filed
• 2026-07-02 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Tenon Medical Inc has 12 institutional holders and institutional ownership of 3.3%.

Insider activity

Insiders reported 23 transactions (3 buys, 0 sells) across 10 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

KALA BIO Inc (KALA) · FIBROBIOLOGICS INC (FBLG) · NEUROSENSE THERAPEUTICS LTD (NRSN) · TransCode Therapeutics Inc (RNAZ) · ENSYSCE BIOSCIENCES INC (ENSC) · LIMINATUS PHARMA INC. (LIMN)